Summary
This company is focused on developing innovative cell therapies aimed at treating various forms of cancer. They specialize in creating invariant T cells as a new standard in cancer treatment, emphasizing the development of universal allogeneic cell therapies. The team consists of experts in biology, immunology, and cell therapy, working towards programmable living therapeutics.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
4.0 years — Since Jan 2021
Web Hosting
Platform
E-Mail Provider
Proofpoint
NAICS Code
541714
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Biotechnology and Cell Therapy
2. Research and Development in Biotechnology (except Nanobiotechnology)
Vendor
Source
TXT Record
Proofpoint
TXT Record
Sendgrid
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|